問卷

TPIDB > Search Result

Search Result

篩選

List

2449Cases

2023-02-01 - 2027-12-31

Phase II

Active
Phase II, Open-label, Single-arm, Multicenter Study of Chidamide in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
  • Condition/Disease

    Relapsed or Refractory Peripheral T-cell Lymphoma

  • Test Drug

    Kepida

Participate Sites
7Sites

Not yet recruiting4Sites

Recruiting3Sites

2021-12-30 - 2025-12-31

Others

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2025-11-13 - 2028-06-28

Phase I

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2020-11-01 - 2026-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2019-08-01 - 2025-12-31

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting7Sites

Terminated1Sites

2022-07-06 - 2025-05-31

Others

Active
An Open-label Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors
  • Condition/Disease

    Endometrial Neoplasms

  • Test Drug

    Tablets Capsules

Participate Sites
6Sites

Terminated6Sites

2020-05-01 - 2024-09-30

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Terminated9Sites

2020-09-20 - 2027-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2020-05-12 - 2025-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting9Sites